Search clinical trials for: Venous Leg Ulcers

Total 278850 results

Eli Lilly and Company
Boehringer Ingelheim

Completed

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

Stress Urinary Incontinence

United States
Charite University, Berlin, Germany

Unknown

HAI Via Interventionally Implanted Port Catheter Systems

Liver Neoplasms | Hepatocellular Carcinoma | Colorectal Cancer | Bile Duct Cancer | Gallbladder Cancer

Germany
Pfizer
PPD

Completed

A First In Human Study Of PF-00184562 In Healthy Volunteers

Schizophrenia

United States
Pfizer

Completed

CP-481,715 Nickel Allergy Study.

Dermatitis, Allergic Contact

United States, Denmark
Eli Lilly and Company

Completed

Duloxetine in the Treatment of Melancholic Depression

Depressive Disorder, Major

Australia, Canada
Eli Lilly and Company

Completed

Switching to Duloxetine From Other Antidepressants

Major Depressive Disorder

Spain, France, Ireland, United Kingdom
Azienda Ospedaliera San Giovanni Battista

Terminated

Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Italy
Pfizer

Completed

Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction

Impotence
Eli Lilly and Company

Completed

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Bipolar Disorder

Spain
Eli Lilly and Company

Completed

Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

Germany, United States, Belgium, France, Norway, Portugal, Spain, Sweden, United Kingdom
Eli Lilly and Company

Completed

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

United States
Eli Lilly and Company

Completed

Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

United States, Argentina, Poland, Romania, Turkey
Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Pfizer

Completed

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Epilepsies, Partial | Epilepsy, Complex Partial

Spain, France, Canada, Germany, Italy, Lithuania, Austria, United Kingdom
Eli Lilly and Company

Completed

Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy

Carcinoma, Non-Small-Cell Lung

Russian Federation
General Hospital Sveti Duh

Completed

Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial

End Stage Renal Disease | Renal Anemia | Regular Dialysis Treatment

Croatia
Kamuzu University of Health Sciences

Completed

Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions

Status Epilepticus | Convulsions

Malawi
Wageningen Centre for Food Sciences
SEAFOODplus

Completed

SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia

Arrhythmia

United Kingdom, Netherlands, Germany, Poland, Belgium, Austria, Czech Republic, Switzerland
International Centre for Diarrhoeal Disease Research...
Pfizer; Tufts Medical Center

Completed

Single Dose Azithromycin in the Treatment of Adult Cholera

Cholera

Bangladesh
Avera Pharmaceuticals

Completed

The Efficacy and Safety of Gantacurium Chloride for Injection in Tracheal Intubation in Healthy Adult Patients Undergoing Surgery Under General Anesthesia

Healthy

Germany
Drug Commission of the German Medical Association
Madaus AG

Terminated

Cholesterol-Lowering Effects of Policosanol

Hypercholesterolemia | Combined Hyperlipidemia
Eli Lilly and Company

Completed

A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia

Schizophrenia

United States
Eli Lilly and Company

Completed

The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis

Sepsis

United States, Canada, Brazil, Mexico, Australia, Czech Republic, Slovakia, Spain, Austria, Belgium, Chile, Denmark, Egypt, Finland, France, Germany, India, Italy, Lebanon, Netherlands, New Zealand, Norway, Romania, Russian Federation, Saudi... and more
Universiteit Antwerpen
Abbott

Completed

Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Oral Flora

Healthy Volunteers

Belgium
Eli Lilly and Company

Completed

ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.

Lung Neoplasms

United States
National Taiwan University Hospital

Unknown

Continuity of Leg Movements in VLBW Premature Infants: From Spontaneous Kicking and Supported Stepping to Independent Walking

Premature Birth
Eli Lilly and Company

Completed

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

United States
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Urologic Neoplasms

Finland, France, Germany
Eli Lilly and Company

Completed

ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer

Cancer | Metastases

United States
National Eye Institute (NEI)

Completed

Laser and Medical Treatment of Diabetic Macular Edema

Macular Degeneration

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

Depression | Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Depression | Pain

United States
Eli Lilly and Company

Completed

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

Pancreatic Neoplasms | Metastases, Neoplasm

United States, France, United Kingdom, Germany, Taiwan, Spain, Belgium, Portugal, Peru, Austria, Italy, Sweden, Netherlands, Venezuela, Argentina, Australia, Colombia, Greece
Eli Lilly and Company

Completed

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Carcinoma, Non-Small-Cell Lung | Neoplasms, Lung | Pulmonary Neoplasms

United States
Eli Lilly and Company

Completed

ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company

Completed

EVA: Evista Alendronate Comparison

Osteoporosis

United States, Canada
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

Urologic Neoplasms | Metastases, Neoplasm

United States
Eli Lilly and Company

Completed

A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, France, Germany, Taiwan, Spain, Belgium, Switzerland, Netherlands, Russian Federation, South Africa, Poland, Hungary, Italy, Norway, India, Sweden, Argentina, United Kingdom, Puerto Rico, Chile, Romania
Eli Lilly and Company

Completed

Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Schizophrenia

United States, United Kingdom, Spain, Argentina, Mexico, Brazil, Peru, Puerto Rico, Germany, Austria, Ireland, Venezuela
Eli Lilly and Company

Completed

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Eli Lilly and Company

Completed

Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

Argentina, Belgium, Brazil, Mexico, Portugal
Eli Lilly and Company

Completed

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

Diabetes Mellitus, Non-Insulin-Dependent

United States
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company

Completed

Comparing 3 Schedules of Alimta Plus Gemzar

Neoplasms | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
Eli Lilly and Company

Completed

A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.

Breast Neoplasms

United States
Eli Lilly and Company

Completed

Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

Breast Neoplasms

United States, Argentina, Chile, India, Mexico
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.

Colorectal Cancer

United States
Eli Lilly and Company

Completed

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.

Colorectal Cancer

United States, Germany
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Bipolar Disorder

United States

Search clinical trials for: Venous Leg Ulcers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations